Purpose
|
Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics, a division of Johnson & Johnson. It is used to treat epilepsy in both children and *****s. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. . A combination product containing phentermine and topiramate extended-release called QSYMIA® is indicated for the management of obesity. On August 2013, an extended released formulation, marketed as Trokendi XR has been approved for the management of partial onset, tonic-clonic, and Lennox-Gastaut Syndrome seizures.
|
Characteristics
|
Tradename: TOPAMAX Source of Compound: synthetic, RWJ-17021 Target: GABAR antagonist,GluR antagonist, Carbonic anhydrase inhibitor Receptor: GABAR,GluR5,Carbonic anhydrase Status: USAN, INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98 %
|
Formula
|
C12H21NO8S
|
Solubility
|
Water: 9.8 mg/ml
|